NMC Health Plc Director/PDMR Shareholding (3043E)
08 February 2018 - 8:08PM
UK Regulatory
TIDMNMC
RNS Number : 3043E
NMC Health Plc
08 February 2018
NMC Health plc
PDMR notification
London, 8 February 2018: NMC Health plc (LSE:NMC) ('NMC'), the
leading United Arab Emirates private healthcare operator with
international services across 13 countries, announces that on 6
February 2018, a trust of which Mr. Henry James Mark Tompkins (an
Independent Non-Executive Director and Joint Chairman of the
Company) is a beneficiary, purchased a total of 3,000 ordinary
shares of 10p each in the Company ("Shares") at an average price of
3192 pence per share.
Following this transaction, Mr Tompkins has an interest over a
total of 56,083 shares, representing approximately 0.03% of the
issued share capital of the Company.
The Notification of Dealing Form for Mr Tompkins can be found
below.
This notification is made in accordance with the Market Abuse
Regulation.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name Henry James Mark Tompkins
--- ---------------- ------------------------------------------
2 Reason for the notification
--- ------------------------------------------------------------
a) Position/status Independent Non-Executive Director of
NMC Health plc
--- ---------------- ------------------------------------------
b) Initial Initial notification
notification
/Amendment
--- ---------------- ------------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name NMC Health plc
--- ---------------- ------------------------------------------
b) LEI 2138008YQEVWBE1V2M52
--- ---------------- ------------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
--- ------------------------------------------------------------
a) Description Ordinary Shares
of the
financial
instrument,
type of
instrument
Identification ISIN: GB00B7FC0762
code
--- ---------------- ------------------------------------------
b) Nature Purchase of shares made through a company
of the owned by a Trust, of which Mark Tompkins
transaction is a beneficiary
--- ---------------- ------------------------------------------
c) Price(s) Price No. of shares
and volume(s)
---- ------------------
3192 pence 3000
----------------------- ------------- ---------------
d) Aggregated
information
- volume 3000
- Price Average price of 3192 pence
- Total GBP95,760.00
----------------------- ------------------------------
e) Date of 6 February 2018
the transaction
---- ------------------ ------------------------------
f) Place of London Stock Exchange
the transaction
---- ------------------ ------------------------------
Contacts
Investors
NMC
Simon Watkins, Group Company
Secretary +44 (0)20 3205 7313
Media:
FTI Consulting, London
Brett Pollard +44 (0)20 3727 1000
FTI Consulting, Gulf
Shane Dolan +971 (0)4 437 2100
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHTPMLTMBMMMAP
(END) Dow Jones Newswires
February 08, 2018 04:08 ET (09:08 GMT)
Nmc Health (LSE:NMC)
Historical Stock Chart
From Apr 2024 to May 2024
Nmc Health (LSE:NMC)
Historical Stock Chart
From May 2023 to May 2024